Pharmaceuticals 2011, 4(1), 7-43; doi:10.3390/ph4010007
Review

GPCR Conformations: Implications for Rational Drug Design

1,* email and 2email
Received: 24 November 2010; in revised form: 20 December 2010 / Accepted: 21 December 2010 / Published: 23 December 2010
(This article belongs to the Special Issue GPCR Based Drug Discovery)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: G protein-coupled receptors (GPCRs) comprise a large class of transmembrane proteins that play critical roles in both normal physiology and pathophysiology. These critical roles offer targets for therapeutic intervention, as exemplified by the substantial fraction of current pharmaceutical agents that target members of this family. Tremendous contributions to our understanding of GPCR structure and dynamics have come from both indirect and direct structural characterization techniques. Key features of GPCR conformations derived from both types of characterization techniques are reviewed.
Keywords: G protein-coupled receptor; GPCR; structure; crystallography; NMR; modeling
PDF Full-text Download PDF Full-Text [1717 KB, uploaded 23 December 2010 12:06 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Parrill, A.L.; Bautista, D.L. GPCR Conformations: Implications for Rational Drug Design. Pharmaceuticals 2011, 4, 7-43.

AMA Style

Parrill AL, Bautista DL. GPCR Conformations: Implications for Rational Drug Design. Pharmaceuticals. 2011; 4(1):7-43.

Chicago/Turabian Style

Parrill, Abby L.; Bautista, Debra L. 2011. "GPCR Conformations: Implications for Rational Drug Design." Pharmaceuticals 4, no. 1: 7-43.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert